Comparative efficacy and safety of paricalcitol versus vitamin D receptor activators for dialysis patients with secondary hyperparathyroidism: a meta-analysis of randomized controlled trials

Peer Review reports

Original Submission
4 May 2016	Submitted	Original manuscript
8 May 2017	Reviewed	Reviewer Report - Lisbet Brandi
19 Jun 2017	Reviewed	Reviewer Report - Wacharee Seeherunvong
11 Jul 2017	Author responded	Author comments - Yifeng Xie
Resubmission - Version 2
11 Jul 2017	Submitted	Manuscript version 2
16 Jul 2017	Reviewed	Reviewer Report - Wacharee Seeherunvong
Resubmission - Version 3
	Submitted	Manuscript version 3
Publishing
18 Aug 2017	Editorially accepted
25 Aug 2017	Article published	10.1186/s12882-017-0691-6

Back to article page